Urinary System Tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years old< = actual age< = 80 years old; 2. Patients with urinary tract tumors confirmed by clinical examination, with indications for laparoscopic surgical treatment and no obvious contraindications to surgery; 3. It is planned to undergo 5G remote surgical treatment in the thoracic and abdominal endoscopic surgery system; 4. Voluntarily participate in this study and sign the informed consent form in writing.
Exclusion criteria
Exclusion criteria: 1. Those with clinical stage IV of malignant tumors; 2. Received abdominopelvic radiotherapy before surgery; 3. Active bleeding, severe abnormal coagulation function (prothrombin time (PT) or international normalized ratio (INR) is higher than 1.5 times the upper limit of normal) or platelet count < 80×10^9/L; 4. Have severe cardiovascular, cerebrovascular or respiratory diseases and cannot tolerate surgery; 5. Participated in other clinical trials in the past 1 month; 6. Inability to understand the requirements of the trial, or unable to complete the study follow-up plan; 7. Other conditions that are considered by the investigator to be unsuitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comlications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Success of the surgery;Intraoperative blood loss;Duration of surgery;Postoperative drain indwelling time;Postoperative urinary catheter indwelling time;Pathological specimens sent for testing; | — |
Countries
China
Contacts
Beijing Hospital